Boston Scientific to Participate in Evercore ISI and Piper Jaffray Healthcare Conferences

MARLBOROUGH, Mass., Nov. 21, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in two investor conferences this December.

Boston Scientific Corporation (PRNewsFoto/Boston Scientific Corporation) (PRNewsFoto/Boston Scientific Corporation)

On Wednesday, December 4, 2019, Susie Lisa, vice president, Investor Relations, and Lauren Tengler, director, Investor Relations, will participate in a 40-minute question-and-answer session with the host analyst at the Evercore ISI HealthCONx Conference in Boston, Massachusetts. The session will begin at approximately 11:00 a.m. EST.

On Thursday, December 5, 2019, Susie Lisa will participate in a 25-minute question-and-answer session with the host analyst at the Piper Jaffray Healthcare Conference in New York City. The session will begin at approximately 11:00 a.m. EST.

A live webcast and replay of the webcast for both events will be accessible at investors.bostonscientific.comhttp://www.bostonscientific.com/investors. The replay will be available beginning approximately one hour following the completion of each event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS


Media:                                             

Investors:

Katie Schur                                               

Susie Lisa, CFA

508-683-5574 (office)                        

508-683-5565 (office)

Media Relations                                     

Investor Relations

Boston Scientific Corporation               

Boston Scientific Corporation

Katie.Schur@bsci.com                            

BSXInvestorRelations@bsci.com

 

SOURCE Boston Scientific Corporation

Top